IL-6 release of Rv0183 antigen-stimulated whole blood is a potential biomarker for active tuberculosis patients

These results clearly show that the Rv0183 antigen-specific IL-6 response has the potential to be used as an immune-diagnosis test for active TB in clinical practice.